Intellipharmaceutics International (IPCIF) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest Intellipharmaceutics International Short Interest DataIntellipharmaceutics International (IPCIF) has a short interest of 500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 12,042 shares to cover all short positions.Current Short Interest500 sharesPrevious Short Interest500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares33,090,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume12,042 sharesToday's Volume Vs. Average0% Short Selling Intellipharmaceutics International? Sign up to receive the latest short interest report for Intellipharmaceutics International and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPCIF Short Interest Over TimeIPCIF Days to Cover Over TimeIPCIF Percentage of Float Shorted Over Time Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Intellipharmaceutics International Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024500 shares $0.00 No ChangeN/A0.2 $0.00 9/30/2024500 shares $0.00 No ChangeN/A5 $0.00 9/15/2024500 shares $0.00 No ChangeN/A5 $0.00 8/31/2024500 shares $0.00 No ChangeN/A0 $0.00 8/15/2024500 shares $0.00 No ChangeN/A0 $0.00 7/31/2024500 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for IPCIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024500 shares $0.00 -28.6%N/A0.3 $0.00 6/30/2024700 shares $52.50 -89.7%N/A0.5 $0.08 6/15/20246,800 shares $680.00 -74.6%N/A1 $0.10 5/31/202426,800 shares $570.84 +61.5%N/A6.7 $0.02 5/15/202416,600 shares $913.00 -5.7%N/A15.1 $0.06 4/30/202417,600 shares $1,056.00 -23.1%N/A0.7 $0.06 4/15/202422,900 shares $1,374.00 -19.9%N/A2.5 $0.06 3/31/202428,600 shares $2,035.18 +2,760.0%N/A1.2 $0.07 3/15/20241,000 shares $25.50 +100.0%N/A0.2 $0.03 2/29/2024500 shares $23.25 No ChangeN/A0.1 $0.05 2/15/2024500 shares $27.00 -84.9%N/A0.1 $0.05 1/15/20243,500 shares $177.45 +9.4%N/A0.2 $0.05 12/31/20233,200 shares $205.44 -61.5%N/A0.1 $0.06 12/15/20238,300 shares $605.07 +3.8%N/A1.5 $0.07 11/30/20238,000 shares $340.00 +166.7%N/A1.5 $0.04 11/15/20233,000 shares $161.40 No ChangeN/A3.8 $0.05 10/31/20233,000 shares $161.10 No ChangeN/A1.8 $0.05 10/15/20233,000 shares $210.00 No ChangeN/A0.1 $0.07 9/30/20233,000 shares $244.50 -6.3%N/A3.3 $0.08 9/15/20233,200 shares $228.80 -3.0%N/A0.6 $0.07 8/31/20233,300 shares $260.37 No ChangeN/A0.4 $0.08 8/15/20233,300 shares $312.18 +6.5%N/A0.2 $0.09 7/31/20233,100 shares $310.00 -62.7%N/A0.1 $0.10 7/15/20238,300 shares $397.57 No ChangeN/A1.4 $0.05 6/30/20238,300 shares $357.52 +1,560.0%N/A1.4 $0.04 6/15/2023500 shares $27.75 No ChangeN/A0 $0.06 5/31/2023500 shares $30.00 No ChangeN/A0.1 $0.06 5/15/2023500 shares $10.00 No ChangeN/A0 $0.02 4/30/2023500 shares $27.50 No ChangeN/A0.2 $0.06 4/15/2023500 shares $30.00 -88.9%N/A0.2 $0.06 3/31/20234,500 shares $243.23 +462.5%N/A0.3 $0.05 3/15/2023800 shares $44.80 -46.7%N/A0.2 $0.06 2/28/20231,500 shares $75.30 +7.1%N/A0.3 $0.05 2/15/20231,400 shares $85.40 +180.0%N/A0.6 $0.06The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth 1/31/2023500 shares $37.08 No ChangeN/A0.4 $0.07 1/15/2023500 shares $44.50 No ChangeN/A0.3 $0.09 12/30/2022500 shares $35.10 -96.2%N/A0 $0.07 12/15/202213,200 shares $951.72 -5.0%N/A2.4 $0.07 11/30/202213,900 shares $1,000.80 -6.1%N/A2.3 $0.07 11/15/202214,800 shares $1,215.08 +5.7%N/A4.8 $0.08 10/31/202214,000 shares $1,142.40 +45.8%N/A2.4 $0.08 10/15/20229,600 shares $873.60 -25.6%N/A1.1 $0.09 9/30/202212,900 shares $1,056.51 -35.5%N/A1.3 $0.08 9/15/202220,000 shares $1,820.00 +29.0%N/A2.1 $0.09 8/31/202215,500 shares $1,376.40 +72.2%N/A7.8 $0.09 8/15/20229,000 shares $907.20 -71.0%N/A1.5 $0.10 7/31/202231,000 shares $3,180.60 -11.9%N/A3.2 $0.10 7/15/202235,200 shares $3,168.00 -12.0%N/A1.5 $0.09 6/30/202240,000 shares $3,720.00 +55.0%N/A3.8 $0.09 6/15/202225,800 shares $2,838.00 +529.3%N/A1.6 $0.11 5/31/20224,100 shares $492.00 +720.0%N/A0.6 $0.12 5/15/2022500 shares $62.85 -28.6%N/A0 $0.13 4/30/2022700 shares $87.50 -69.6%N/A0 $0.13 4/15/20222,300 shares $299.00 -51.1%N/A0.2 $0.13 3/31/20224,700 shares $614.76 -37.3%N/A0.5 $0.13 3/15/20227,500 shares $951.00 -24.2%N/A0.5 $0.13 2/28/20229,900 shares $1,270.17 +191.2%N/A1 $0.13 2/15/20223,400 shares $436.90 -22.7%N/A0.4 $0.13 1/31/20224,400 shares $501.60 No ChangeN/A0.4 $0.11 1/15/20224,400 shares $731.72 +83.3%N/A0.1 $0.17 12/31/20212,400 shares $301.20 +380.0%N/A0 $0.13 12/15/2021500 shares $42.80 -16.7%N/A0 $0.09 11/30/2021600 shares $72.00 +20.0%N/A0 $0.12 11/15/2021500 shares $64.95 No ChangeN/A0 $0.13 10/29/2021500 shares $74.25 No ChangeN/A0.1 $0.15 10/15/2021500 shares $65.00 No ChangeN/A0.1 $0.13 9/30/2021500 shares $67.50 -16.7%N/A0.1 $0.14 9/15/2021600 shares $81.42 -89.1%N/A0.2 $0.14 8/31/20215,500 shares $833.80 +189.5%N/A0.4 $0.15 8/13/20211,900 shares $316.73 +280.0%N/A0.2 $0.17 7/30/2021500 shares $88.55 -95.4%N/A0 $0.18 7/15/202110,800 shares $1,728.00 +145.5%N/A0.6 $0.16 6/30/20214,400 shares $797.28 -47.0%N/A0.2 $0.18 6/15/20218,300 shares $1,823.51 +361.1%N/A0.2 $0.22 5/28/20211,900 shares $345.42 +111.1%N/A0.3 $0.18 5/14/2021900 shares $173.52 -59.1%N/A0 $0.19 4/30/20212,200 shares $514.80 -81.7%N/A0.1 $0.23 4/15/202112,000 shares $2,764.80 +60.0%N/A0.3 $0.23 3/31/20217,500 shares $1,500.00 No ChangeN/A0.1 $0.20 3/15/20217,500 shares $1,500.00 -44.0%N/A0.1 $0.20 2/26/202113,400 shares $4,020.00 -22.5%N/A0.1 $0.30 2/12/202117,300 shares $5,440.85 -81.6%N/A0 $0.31 1/29/202194,000 shares $14,560.60 +45.1%N/A1.4 $0.15 1/15/20219,800 shares $1,568.00 +58.1%N/A0.5 $0.16The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth 12/31/20206,900 shares $897.00 -29.6%N/A0.1 $0.13 12/15/20209,800 shares $1,412.18 +58.1%N/A0.5 $0.14 11/30/20206,200 shares $815.92 +933.3%N/A0.1 $0.13 11/15/2020600 shares $82.56 -78.6%N/A0 $0.14 10/30/20202,800 shares $446.60 -86.3%N/A0 $0.16 10/15/202020,400 shares $2,431.68 +827.3%N/A0.2 $0.12 9/30/20202,200 shares $264.00 +340.0%N/A0.1 $0.12 9/15/2020500 shares $64.50 -64.3%N/A0 $0.13 8/31/20201,400 shares $196.00 +7.7%N/A0.1 $0.14 8/14/20201,300 shares $183.04 -56.7%N/A0 $0.14 7/31/20203,000 shares $451.50 +150.0%N/A0.1 $0.15 7/15/20201,200 shares $170.64 -75.5%N/A0 $0.14 6/30/20204,900 shares $681.10 +880.0%N/A0.1 $0.14 6/15/2020500 shares $73.00 -91.9%N/A0 $0.15 5/29/20206,200 shares $845.68 -27.9%N/A0.1 $0.14 5/15/20208,600 shares $1,216.04 +405.9%N/A0.2 $0.14 4/30/20201,700 shares $266.22 -96.3%N/A0 $0.16 4/15/202045,300 shares $5,934.30 -71.6%N/A1.2 $0.13 3/31/2020159,700 shares $23,955.00 -40.5%N/A1 $0.15 3/13/2020268,200 shares $32,184.00 +10.3%N/A3 $0.12 2/28/2020243,100 shares $30,217.33 +0.8%N/A3.2 $0.12 2/14/2020241,200 shares $31,356.00 +7.4%N/A1.9 $0.13 1/31/2020224,500 shares $39,287.50 -50.1%N/A0.2 $0.18 1/15/2020449,600 shares $76,432.00 +157.7%N/A0.3 $0.17 12/31/2019174,500 shares $29,665.00 +101.0%N/A0.4 $0.17 IPCIF Short Interest - Frequently Asked Questions What is Intellipharmaceutics International's current short interest? Short interest is the volume of Intellipharmaceutics International shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 500 shares of IPCIF short. Learn More on Intellipharmaceutics International's current short interest. How does Intellipharmaceutics International's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Intellipharmaceutics International: Akari Therapeutics, Plc (0.15%), ProMIS Neurosciences, Inc. (0.60%), Bullfrog AI Holdings, Inc. (4.80%), Cocrystal Pharma, Inc. (0.52%), Athira Pharma, Inc. (4.41%), Finch Therapeutics Group, Inc. (2.83%), Charlie's Holdings, Inc. (0.00%), Galmed Pharmaceuticals Ltd. (1.77%), TherapeuticsMD, Inc. (0.21%), Minerva Neurosciences, Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Intellipharmaceutics International stock? Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intellipharmaceutics International? A short squeeze for Intellipharmaceutics International occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPCIF, which in turn drives the price of the stock up even further. How often is Intellipharmaceutics International's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPCIF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Akari Therapeutics Short Interest Data ProMIS Neurosciences Short Interest Data Bullfrog AI Short Interest Data Cocrystal Pharma Short Interest Data Athira Pharma Short Interest Data Finch Therapeutics Group Short Interest Data Charlie's Short Interest Data Galmed Pharmaceuticals Short Interest Data TherapeuticsMD Short Interest Data Minerva Neurosciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPCIF) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPCIF Stock Alerts